- Home
- / Asensus Surgical
Asensus Surgical
Revenue
$8.6 M
FY, 2023
Asensus Surgical Summary
Company Summary
- Overview
- Asensus Surgical (formerlyTransEnterix) is a company developing digital surgical technology. It offers Senhance Surgical System, Senhance Connect, a digital collaboration platform, Senhance Simulation, a vrobotic surgery simulation, and other solutions.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2006
- HQ
- Durham, NC, US | view all locations
- Website
- https://asensus.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Anthony Fernando, President, Chief Executive Officer and Director
Wesley Long, Vice President of Customer Excellence
Amanda Owens, Global Head of People
Operating MetricsView all
Patent Applications
150
FY, 2021
Patents (Foreign)
100
FY, 2021
Facility Space Leased (Italy), sq. ft.
11.7K
4.1%
FY, 2021
LocationsView all
5 locations detected
Durham, NC HQ
United States
1 TW Alexander Dr #160
Milano, Lombardia
Italy
Viale dell’Innovazione 3
Tokyo, Tokyo
Japan
4-7-35 Kita-Shinagawa Gotenyama Trust Tower, 12th floor
Bertrange, District de Luxembourg
Luxembourg
33 Rue du puits Romain
Lugano, TI
Switzerland
Via Serafino Balestra 12
Asensus Surgical Financials
Summary Financials
- Revenue (Q2, 2024)
- $2.2M
- Gross profit (Q2, 2024)
- ($452.0K)
- Net income (Q2, 2024)
- ($25.7M)
- Cash (Q2, 2024)
- $7.8M
- EBIT (Q2, 2024)
- ($23.5M)